Osaic Holdings’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-542
Closed -$21.3K 7687
2023
Q2
$21.3K Buy
542
+34
+7% +$1.2K ﹤0.01% 5521
2023
Q1
$12.4K Buy
508
+163
+47% +$3.57K ﹤0.01% 5855
2022
Q4
$7K Sell
345
-89
-21% -$1.9K ﹤0.01% 6160
2022
Q3
$8K Buy
434
+420
+3,000% +$5.51K ﹤0.01% 6155
2022
Q2
$0 Buy
+14
New +$176 ﹤0.01% 7732
2021
Q1
Sell
-135
Closed -$1K 7012
2020
Q4
$1K Hold
135
﹤0.01% 6317
2020
Q3
$1K Hold
135
﹤0.01% 6117
2020
Q2
$1K Sell
135
-165
-55% -$687 ﹤0.01% 6026
2020
Q1
$1K Buy
+300
New +$1.75K ﹤0.01% 5969

Osaic Holdings's ISEE Position: Q3 2023 in Review

Osaic Holdings sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 542 shares — an estimated $21.3K sold.

Osaic Holdings first reported a position in ISEE in Q1 2020 and held it in 9 quarters. The position peaked at $21.3K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Osaic Holdings reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Osaic Holdings sold 542 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $21.3K.
  • Osaic Holdings first reported a position in IVERIC bio, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
  • Osaic Holdings's IVERIC bio, Inc. Common Stock position peaked at $21.3K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.